logo
15:59 May 29

Bal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
90.12
-6.31 (-6.54%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bal Pharma Ltd. Financials

Bal Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
90.12
-6.31 (-6.54%)
15:59 May 29
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

47/100
Mid Valuation

Technical

59/100
Technically Neutral

Strength

6

Weakness

7

Opportunity

0

Threats

0

7.68 %

ROE %

1.68 %

ROA %

3.95

EPS

51.65

BVPS

2.02 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
281.21 304.22 339.22 303.08 311.66
Operating Expenses +
257.73 279.09 307.69 273.53 279.75
Raw Material
172.42 190.64 192.82 164.95 170.2
Increase Decrease in Cost
-4.89 -17.87 -1.06 -7.05 -12.23
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
47.25 55.3 60.38 62.4 66.46
Miscellaneous Expenses
59.81 73.92 78.03 83.35 73.78
Operating Profit
23.48 25.13 31.53 29.55 31.91
Other Income
5.15 0.94 2.85 2.2 1.93
Depreciation
9.04 9.13 10.07 9.77 11.08
Interest
10.41 12.19 15.26 16.85 16.82
Profit before tax and exceptio..
9.18 4.75 9.05 5.14 5.94
Exceptional Items
0 0 0 0 0
PBT
9.18 4.75 9.05 5.14 5.94
Provision for Taxation
3.48 2.13 1.6 -2.1 -0.39
Net Profit
5.7 2.62 7.45 7.24 6.32
NET Profit after MI
5.61 2.57 7.39 7.22 6.32
EPS
3.79 1.67 4.94 4.54 3.95
Operating Profit Margin (%)
8.35 8.26 9.29 9.75 10.24
Net Profit Margin (%)
2 0.84 2.18 2.38 2.03

Bal Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 50.90 50.90 50.90 50.90 50.90 50.90
FII 0.10 0.10 0.20 0.20 0.10 0.10
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 49.00 49.00 48.90 48.90 49.00 49.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: